Filing Flows › Exagen (XGN) › Free cash flow
Exagen (XGN) free cash flow by quarter
Exagen's free cash flow was $3.4M in Q2 2026 (second quarter 2026), +29% from Q3 2025. Over the last 3 quarters it ranged from $217K (Q4 2024) to $3.4M (Q2 2026).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $3.4M | +29% | — |
| Q3 2025 | $2.7M | 12× | — |
| Q4 2024 | $217K | — | — |
Q2 2026 at a glance
Exagen, Q2 2026: revenue $19.9M (+16% year over year), operating margin -8.6%, net loss $3.2M, operating cash flow $4.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Exagen's free cash flow?
Exagen's free cash flow was $3.4M in Q2 2026 (second quarter 2026), +29% from Q3 2025.
How has Exagen's free cash flow changed?
Over the last 3 quarters it ranged from $217K (Q4 2024) to $3.4M (Q2 2026).